MOMENTUM: momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemic.
Miklós Egyed, Chih-Cheng Chen, Srdan Verstovsek, Martin Ellis, Mary F McMullin, Ruben A Mesa, Mark M Kowalski, Sung-Soo Yoon, Alessandro Vannucchi, Christof Scheid, Uwe Platzbecker, Andrew Perkins, Stephen T Oh, Donal McLornan, Adam Mead, Mihaela C Lazaroiu, Jean-Jacques Kiladjian, Claire Harrison, Vikas Gupta, Yeow T Goh, Laura Fox
Future oncology (London, England) 2021;17(12):1449-1458